Log in to save to my catalogue

CAR-T cell therapy: current limitations and potential strategies

CAR-T cell therapy: current limitations and potential strategies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_40c1ba0f2ef74dd8953be161f136eb35

CAR-T cell therapy: current limitations and potential strategies

About this item

Full title

CAR-T cell therapy: current limitations and potential strategies

Publisher

London: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2021-04, Vol.11 (4), p.69-11, Article 69

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Chimeric antigen receptor (CAR)-T cell therapy is a revolutionary new pillar in cancer treatment. Although treatment with CAR-T cells has produced remarkable clinical responses with certain subsets of B cell leukemia or lymphoma, many challenges limit the therapeutic efficacy of CAR-T cells in solid tumors and hematological malignancies. Barriers t...

Alternative Titles

Full title

CAR-T cell therapy: current limitations and potential strategies

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_40c1ba0f2ef74dd8953be161f136eb35

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_40c1ba0f2ef74dd8953be161f136eb35

Other Identifiers

ISSN

2044-5385

E-ISSN

2044-5385

DOI

10.1038/s41408-021-00459-7

How to access this item